PDF herunterladen
Frauenheilkunde up2date 2025; 19(02): 113-118
DOI: 10.1055/a-2358-0507
Schritt für Schritt

Sentinel-Lymphknoten-Biopsie – Schritt für Schritt

Annett Spogis
,
Markus Hahn
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Die Detektion und Darstellung des Sentinel-Lymphknotens ist eine etablierte Methode in der Diagnostik des Mammakarzinoms. Radioaktive Tracer oder auch Farbstoffe werden zur Visualisierung der Lymphknoten eingesetzt. Der folgende Beitrag führt Schritt für Schritt durch eine Sentinel-Lymphknoten-Biopsie. Dabei werden die Vorteile der Verwendung von Indocyaningrün deutlich.

Schlüsselwörter

Sentinel-Lymphknoten - Biopsie - Mammakarzinom - Indikation - Indocyaningrün - Durchführung


Publikationsverlauf

Artikel online veröffentlicht:
31. März 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Robert Koch-Institut. Zentrum für Krebsregisterdaten. Brustkrebs (Mammakarzinom). Zugriff am 15. Januar 2025 unter: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Brustkrebs/brustkrebs_node.html
  • 2 Fisher B, Redmond C, Fisher ER. et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-681
    CrossrefPubMedSuche in Google Scholar
  • 3 Krag DN, Weaver DL, Alex JC. et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339 discussion 340
    CrossrefPubMedSuche in Google Scholar
  • 4 Kuehn T, Bembenek A, Decker T. et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005; 103: 451-461
    CrossrefPubMedSuche in Google Scholar
  • 5 Krag D, Weaver D, Ashikaga T. et al. The Sentinel Node in Breast Cancer — A Multicenter Validation Study. N Engl J Med 1998; 339: 941-946
    CrossrefPubMedSuche in Google Scholar
  • 6 Veronesi U, Paganelli G, Viale G. et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553
    CrossrefPubMedSuche in Google Scholar
  • 7 Krag DN, Anderson SJ, Julian TB. et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 927-933
    CrossrefPubMedSuche in Google Scholar
  • 8 Albertini JJ. Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer. JAMA 1996; 276: 1818-1822
    CrossrefSuche in Google Scholar
  • 9 Bromham N, Schmidt-Hansen M, Astin M. et al. Axillary treatment for operable primary breast cancer. Cochrane Database Syst Rev 2017; (01) CD004561
    CrossrefPubMedSuche in Google Scholar
  • 10 Chagpar A, Martin 3rd RC, Chao C. et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004; 139: 614-618 discussion 618–620
    CrossrefPubMedSuche in Google Scholar
  • 11 Tanis PJ, Nieweg OE, Valdes Olmos RA. et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001; 192: 399-409
    CrossrefPubMedSuche in Google Scholar
  • 12 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, AWMF Registernummer: 032–045OL. 2021 Zugriff am 15. Januar 2025 unter: https://register.awmf.org/de/leitlinien/detail/032-045OL
    Suche in Google Scholar
  • 13 Arbeitsgemeinschaft Gynäkologische Onkologie e. V. (AGO). Leitlinien & Empfehlungen | Guidelines. Empfehlungen gynäkologische Onkologie Kommission Mamma. Zugriff am 15. Januar 2025 unter: https://www.ago-online.de/leitlinien-empfehlungen/leitlinien-empfehlungen/kommission-mamma
  • 14 Intra M, Viale G, Vila J. et al. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology. Ann Surg Oncol 2015; 22: 2372-2377
    CrossrefPubMedSuche in Google Scholar
  • 15 Kaminski A, Amr D, Kimbrell ML. et al. Lymphatic mapping in patients with breast cancer and previous augmentation mammoplasty. Am Surg 2007; 73: 981-983
    CrossrefPubMedSuche in Google Scholar
  • 16 Gerber B, Heintze K, Stubert J. et al. Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?. Breast Cancer Res Treat 2011; 128: 613-624
    CrossrefPubMedSuche in Google Scholar
  • 17 Gentilini OD, Botteri E, Sangalli C. et al. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. JAMA Oncol 2023; 9: 1557-1564
    CrossrefPubMedSuche in Google Scholar
  • 18 Reimer T, Stachs A, Veselinovic K. et al. Axillary Surgery in Breast Cancer – Primary Results of the INSEMA Trial. N Engl J Med 2024;
    CrossrefPubMedSuche in Google Scholar
  • 19 Singletary SE. Surgical management of inflammatory breast cancer. Semin Oncol 2008; 35: 72-77
    CrossrefPubMedSuche in Google Scholar
  • 20 Hidar S, Bibi M, Gharbi O. et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 2009; 7: 272-275
    CrossrefPubMedSuche in Google Scholar
  • 21 Douek M, Klaase J, Monypenny I. et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol 2014; 21: 1237-1245
    CrossrefPubMedSuche in Google Scholar
  • 22 Grischke EM, Rohm C, Hahn M. et al. ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial. Geburtshilfe Frauenheilkd 2015; 75: 935-940
    Thieme ConnectPubMedSuche in Google Scholar
  • 23 Thill M, Kurylcio A, Welter R. et al. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast 2014; 23: 175-179
    CrossrefPubMedSuche in Google Scholar
  • 24 Perenyei M, Barber ZE, Gibson J. et al. Anaphylactic Reaction Rates to Blue Dyes Used for Sentinel Lymph Node Mapping: Systematic Review and Meta-analysis. Ann Surg 2021; 273: 1087-1093
    CrossrefPubMedSuche in Google Scholar
  • 25 Nguyen CL, Zhou M, Easwaralingam N. et al. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial. Ann Surg Oncol 2023; 30: 6520-6527
    CrossrefPubMedSuche in Google Scholar
  • 26 Motomura K, Inaji H, Komoike Y. et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 2001; 76: 95-99
    CrossrefPubMedSuche in Google Scholar
  • 27 Krikanova M, Biggar M, Moss D. et al. Accuracy of sentinel node biopsy for breast cancer using blue dye alone. Breast J 2010; 16: 384-388
    CrossrefPubMedSuche in Google Scholar
  • 28 Bargon CA, Huibers A, Young-Afat DA. et al. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial. Ann Surg 2022; 276: 913-920
    CrossrefPubMedSuche in Google Scholar
  • 29 Ballardini B, Santoro L, Sangalli C. et al. The indocyanine green method is equivalent to the (9)(9)mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol 2013; 39: 1332-1336
    CrossrefPubMedSuche in Google Scholar
  • 30 Kedrzycki MS, Leiloglou M, Ashrafian H. et al. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery. Ann Surg Oncol 2021; 28: 3738-3748
    CrossrefPubMedSuche in Google Scholar
  • 31 Bourgeois P, Roman MM, Schweicher J. et al. Lymphatic Alterations Under Tattoos: Preliminary Reports of One Observational Study. Clin Cosmet Investig Dermatol 2023; 16: 257-265
    CrossrefPubMedSuche in Google Scholar
  • 32 Rubio IT, Rodriguez-Revuelto R, Espinosa-Bravo M. et al. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study. Eur J Surg Oncol 2020; 46: 2195-2201
    CrossrefPubMedSuche in Google Scholar
  • 33 Christenhusz A, Pouw JJ, Simonis FFJ. et al. Breast MRI in patients after breast conserving surgery with sentinel node procedure using a superparamagnetic tracer. Eur Radiol Exp 2022; 6: 3
    CrossrefPubMedSuche in Google Scholar
  • 34 Aribal E, Celik L, Yilmaz C. et al. Effects of iron oxide particles on MRI and mammography in breast cancer patients after a sentinel lymph node biopsy with paramagnetic tracers. Clin Imaging 2021; 75: 22-26
    CrossrefPubMedSuche in Google Scholar
  • 35 Rubio IT, Diaz-Botero S, Esgueva A. et al. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol 2015; 41: 46-51
    CrossrefPubMedSuche in Google Scholar
  • 36 Houpeau JL, Chauvet MP, Guillemin F. et al. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial. J Surg Oncol 2016; 113: 501-507
    CrossrefPubMedSuche in Google Scholar